gen labs tirzepatide 10mg — GLP-1/GIP Dual-Agonist Research Peptide Compounded GLP-1 - Semaglutide &
Description
Use of the weight loss drug Wegovy cut the chances of patients dying from Covid by roughly a third compared to placebo, a new analysis found.
What does this mean for their long-term health?
It found semaglutide reduced risk of major kidney events by 24% for type 2 diabetes patients, but GPs have urged caution.
Cardiovascular Benefits: Reduces the risk of major adverse cardiovascular events in patients with type 2 diabetes and high cardiovascular risk.
Similarly, side effects can be a major hurdle for some people
